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1 |  INTRODUCTION
Atrial fibrillation recurrences after pulmonary vein isolation 
(PVI) may not only be caused by reconduction but also by 
the presence of an arrhythmogenic substrate elsewhere in the 
atria. In many patients (40%‐60%), AF tends to recur, also 
after multiple initially successful PVIs.1 Even additional sub-
strate modification consisting of, for example, ablation of 
complex fractionated electrograms does not cure AF in the 
vast majority of these patients.2
Intraoperative high‐resolution epicardial mapping pro-
vides insight into the severity of the arrhythmogenic sub-
strate underlying persistence of AF. In the present case, we 
applied this technique to the entire atrial epicardial surface of 
a patient with a history of multiple failed ablations, to com-
prehend why currently available therapeutic strategies for AF 
were all prone to fail.
2 |  CASE REPORT
We present a male patient with longstanding persistent AF, 
who was diagnosed with paroxysmal AF at the age of 31. 
Failed antiarrhythmic drug therapy included amiodarone, 
sotalol, and metoprolol. For prevention of thrombo‐embolic 
events, he used a vitamin K antagonist.
At age 49, transthoracic echocardiography showed left 
atrial dilatation (55 × 65 mm) with secondary mitral valve 
insufficiency and mild left ventricular dilatation (end‐di-
astolic dimension 61  mm). Left ventricular function was 
normal, and presence of coronary artery disease was ruled 
out by coronary angiography. The patient was referred to 
our hospital for mitral valve repair and concomitant surgi-
cal PVI (sPVI). A box lesion was created around the ostia 
of the pulmonary veins at the left atrial posterior wall using 
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Abstract
Atrial fibrillation (AF) often recurs after ablative therapy. In our patient, intraop-
erative epicardial mapping during therapy‐ resistant AF revealed highly dissociated 
atrial conduction patterns and that long lines of conduction block throughout the 
entire atria. Given the extensiveness of the substrate, it is not surprising that ablations 
were not successful.
Conduction patterns during therapy‐resistant atrial fibrillation (AF) are highly dissociated 
and show long lines of conduction block. As long as the presence and extensiveness of the ar-
rhythmogenic substrate underlying AF remains poorly understood and cannot be evaluated in 
the individual patient, none of the present available antiarrhythmic treatment modalities will 
be effective.
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the Epicor Cardiac Ablation System (St Jude/Abbott). With 
this device, isolation of the pulmonary veins is achieved by 
the use of high‐intensity focused ultrasound. In addition, an 
mitral isthmus line was created extending from the caudal 
side of the box lesion to the mitral valve annulus (crossing 
the coronary sinus), and the left atrial appendage was am-
putated. Exit pacing was performed after surgical creation 
of the box lesion.
In the following years, he developed numerous AF re-
currences in addition to a typical atrial flutter and multiple 
atrial tachyarrhythmias (AT), all requiring electrical cardio-
version. As a consequence, three endovascular right‐sided 
ablation procedures were performed, including the creation 
of a linear lesion across the cavo‐tricuspid isthmus and two 
unsuccessful ablations of different right‐sided focal ATs. 
Immediate success after the consecutive endovascular ab-
lation procedures (procedures 2nd‐5th) was confirmed by 
the presence of a bidirectional block and/or noninducibility 
of AT.
Seven years after the initial sPVI, he was referred for redo 
sPVI (age 55). As the patient participated in a research proj-
ect (QUASAR MEC2010‐393), an intraoperative, high‐reso-
lution epicardial mapping procedure of the right and left atria 
and Bachmann's Bundle was performed during a persistent 
AF episode.
A series of wavemaps, constructed during 790 millisec-
onds (ms) of AF, recorded at the right atrial free wall is shown 
in Figure 1. This site was selected as it was not targeted by 
any of the previous ablation procedures and thus represents 
physiological atrial conduction in this patient, without the 
presence of potential iatrogenic conduction block, caused by 
earlier ablation. Activation of atrial tissue was highly dissoci-
ated due to multiple epicardial breakthrough waves and lines 
of conduction block, resulting in 66 fibrillation waves in only 
790 ms Conduction block was omnipresent. In five consec-
utive wavemaps, the total lengths of all lines of conduction 
block were 78 mm (wavemap 1), 78 mm (wavemap 2), 48 mm 
(wavemap 3), 136 mm (wavemap 4), and 90 mm (wavemap 
5). This corresponds with respectively 11.3%, 11.3%, 7.0%, 
19.8%, and 13.1% of the mapping area. At all other map-
ping sites in the remainder of the atria, patterns of activation 
were highly complex and varied from beat to beat. Epicardial 
breakthrough waves (EBW) were present in all wavemaps. 
The total amount was 31 and varied from 5 (wavemap 1) to 8 
(wavemap 5) EBW per wavemap. This translates to 39 EBW 
per second at this specific mapping site.
After redo sPVI, electrical isolation was confirmed by the 
presence of an entrance block. One day after surgery, AF re-
curred. In addition, the patient developed bradycardia (day 
3) for which a permanent DDD pacemaker was implanted. 
Three years later, the patient still had ongoing AF episodes 
and a His bundle ablation was performed to control the ven-
tricular heart rate.
3 |  DISCUSSION
The present case emphasizes the major importance of knowl-
edge of the presence and extensiveness of the arrhythmo-
genic substrate underlying AF in the individual patient. In 
our patient, the highly complex atrial activation patterns and 
numerous EBW are indicative of substrate mediated AF. It 
is therefore to be expected that PVI will not be effective in 
eliminating AF.
Prior studies showed that EBW are key elements of the 
arrhythmogenic substrate underlying AF3 and result most 
likely from endo‐epicardial dissociation.4 Substrate mod-
ification, such as ablation of complex fractionated electro-
grams or ganglionic plexi, or deployment of linear lesions 
for AF was not executed. However, these therapies are fo-
cusing on the substrate as more or less localized pathology, 
whereas in this case, electropathology is present diffusely 
throughout the entire left and right atria and Bachmann's bun-
dle. Hence, even additional substrate modifying techniques 
would not have cured AF in this patient given the extensive-
ness of the arrhythmogenic substrate and the asynchronicity 
of activation patterns. Given the ever‐growing population of 
patients with therapy‐resistant AF, further research into the 
F I G U R E  1  Patterns of activation. 
Wavemaps illustrating the high complexity 
of patterns of atrial activation during atrial 
fibrillation. Different colors indicate the 
consecutive fibrillation waves. Arrows 
indicate the main trajectory of each 
fibrillation wave. Black arrow: peripheral 
fibrillation wave. White arrow: epicardial 
breakthrough (“focal”) wave
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arrhythmogenic substrate associated with AF persistence and 
ultimately development of new (patient tailored) therapeutic 
strategies are of utmost importance.
4 |  CONCLUSION
The current case illustrates that as long as the presence and 
extensiveness of the arrhythmogenic substrate underlying AF 
remains poorly understood and cannot be evaluated in the in-
dividual patient, none of the present available antiarrhythmic 
treatment modalities will be effective.
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